menu search

Schrödinger to present new preclinical data from its cdc7 inhibitor program at american society of hematology 2022 annual meeting

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and mate...

November 3, 2022, 9:23 am

U.s. appeals court upholds $14 million judgment against exxon

The U.S. Fifth Circuit Court of Appeals in New orleans on Tuesday upheld a $14.25 million judgment agai...

August 31, 2022, 6:15 pm

Entergy to report second-quarter 2022 financial results on aug. 3

NEW orleans , July 27, 2022 /PRNewswire/ -- Entergy will report its second-quarter 2022 financial resu...

July 27, 2022, 6:50 pm

Tesla lays off 200 autopilot workers, turkey allows sweden-finland nato membership, ftc sues walmart

Yahoo Finance anchor Julie Hyman reports today's notable business headlines including reports of Tesla laying off 200 workers in its autopilot unit, T...

June 29, 2022, 11:06 am

National energy services reunited corp. to participate in upcoming conferences

HOUSTON, TX / ACCESSWIRE / May 18, 2022 / National Energy Services Reunited Corp. ("NESR" or "the Company") (NASDAQ:NESR)(NASDAQ:NESRW), an internatio...

May 18, 2022, 4:52 pm

Zynerba pharmaceuticals announces presentation of poster on zygel at the 2022 society of biological psychiatry annual meeting

Zynerba Pharmaceuticals (NASDAQ:ZYNE) Inc said it presented a poster on the long-term safety and efficacy of its cannabidiol transdermal gel, Zygel, a...

May 2, 2022, 9:24 am

Pool corporation cfo to present at the 25th annual burkenroad reports investment conference

COVINGTON, La., April 22, 2022 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq:POOL) announced today that Melanie M. Hart, Vice President and Chief Finan...

April 22, 2022, 4:05 pm

Aim immunotech reports positive data from phase 2a study evaluating ampligen as part of a regimen treating colorectal cancer that has spread to the liver

AIM ImmunoTech Inc (NYSE:AIM) presented positive data from its ongoing Phase 2a clinical study at the Roswell Park Comprehensive Cancer Center evalua...

April 11, 2022, 11:47 am

Celsion and medidata to present findings on use of synthetic control arm to estimate treatment effect in ovarian cancer trial

Phase Ib dose-escalating OVATION I Study with GEN-1 in advanced ovarian cancer patients to be presented at 2022 AACR A nnual M eeti ng being held Apri...

April 6, 2022, 8:30 am

Investors hoping for news at cancer meeting that will boost share prices

Given that developing biotechnology companies are more susceptible to swings in stock price than established ones, investors might want to keep an eye...

March 10, 2022, 5:30 pm

Shattuck labs to present two posters at the 2022 american association for cancer research (aacr) annual meeting

AUSTIN, Texas and DURHAM, N.C., March 09, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology compa...

March 9, 2022, 8:21 am

Caribou biosciences to present preclinical data on cb-011, an immune-cloaked allogeneic anti-bcma car-t cell therapy, at the american association for cancer research (aacr) annual meeting

BERKELEY, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharm...

March 8, 2022, 8:19 pm

Omega therapeutics to present preclinical data for otx-2002 at the american association for cancer research annual meeting 2022

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a development-stage biotechnology company pioneeri...

March 8, 2022, 5:05 pm

Theseus pharmaceuticals to present preclinical data characterizing next-generation epidermal growth factor receptor (egfr) inhibitors at the 2022 american association for cancer research (aacr) annual

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceut...

March 8, 2022, 5:01 pm

Theseus pharmaceuticals to present preclinical data characterizing next-generation epidermal growth factor receptor (egfr) inhibitors at the 2022 american association for cancer research (aacr) annual

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceut...

March 8, 2022, 5:01 pm

Theseus pharmaceuticals to present preclinical data characterizing next-generation epidermal growth factor receptor (egfr) inhibitors at the 2022 american association for cancer research (aacr) annual

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceut...

March 8, 2022, 5:01 pm

Sqz biotechnologies to present new enhanced apc platform preclinical findings and envoy-001 phase 1/2 clinical trial in progress poster at the american association for cancer research 2022 annual meet

WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple the...

March 8, 2022, 4:45 pm

Sqz biotechnologies to present new enhanced apc platform preclinical findings and envoy-001 phase 1/2 clinical trial in progress poster at the american association for cancer research 2022 annual meet

WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple the...

March 8, 2022, 4:45 pm

Xencor to present preclinical data from xmab® cytokine programs at the american association for cancer research (aacr) annual meeting 2022

MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytoki...

March 8, 2022, 4:31 pm

Entergy to report 2021 financial results on feb. 23

NEW orleans , Feb. 16, 2022 /PRNewswire/ -- Entergy will report its 2021 financial results before the m...

February 16, 2022, 6:29 pm


Search within

Pages Search Results: